Melinda Weber, DNP, RN, APN, AOCN, C.
Articles by Melinda Weber, DNP, RN, APN, AOCN, C.
Drivers for Interest in Subcutaneous Treatment in Oncology Practices and Clinic Workflow Changes
ByRoxana S. Dronca, MD, Melinda Weber, DNP, RN, APN, AOCN, C. ,Kirollos S. Hanna, PharmD, BCPS, BCOP Panelists discuss how subcutaneous immune checkpoint inhibitors transform cancer care delivery by streamlining clinical workflows through faster administration in alternative care settings, improving patient quality of life by reducing treatment time and allowing greater flexibility in scheduling, and expanding access through home-based programs that serve rural and underserved populations while maintaining comprehensive monitoring and support systems.
Challenges in IV Administration of Immune Checkpoint Inhibitors and Interest in Subcutaneous Formulations
ByRoxana S. Dronca, MD, Melinda Weber, DNP, RN, APN, AOCN, C. ,Kirollos S. Hanna, PharmD, BCPS, BCOP Panelists discuss how IV administration of immune checkpoint inhibitors creates operational challenges, including infusion chair bottlenecks, complex scheduling, venous access difficulties, and time burdens for patients, while subcutaneous formulations offer potential solutions through simplified delivery, reduced infusion center strain, and improved patient convenience.
